Oakbio

About:

Oakbio creates technologies that transform carbon emissions from harmful waste into high value products.

Top Investors: IndieBio, SOSV, EASME - EU Executive Agency for SMEs

Description:

Oakbio creates technologies that transform carbon emissions from harmful waste into high value products. Oakbio is a “Carbon Capture and Utilization/Conversion” (CCU) company. Our Vision is to profitably convert CO2 and other green house gases (GHGs) into valuable products. Unlike other companies who are producing relatively low value biofuels, Oakbio is focused on renewable products that are inherently valuable and profitable in and of themselves, with or without a carbon tax or subsidy. Oakbio’s core competency is its deep understanding of microbial metabolism and pathways, and its proven technology platforms. Oakbio’s business model is to partner with established industrial businesses to develop low capex/opex carbon capture and utilization biofactories based on Oakbio’s core technologies.

Total Funding Amount:

$26.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Sunnyvale, California, United States

Founded Date:

2009-01-01

Founders:

Brian Sefton, Pierre Pujol

Number of Employees:

1-10

Last Funding Date:

2024-07-23

IPO Status:

Private

Industries: